Sources and sharing

ONCY - ONCOLYTICS BIOTECH INC Noncurrent Liabilities

Context
Latest reported period: Q4 2020
Latest reported value
CA$6,883,461

Based on company facts extracted from SEC 10-Q/10-K XBRL filings where available. Values may differ by reporting period and company taxonomy.

Tracking and update notes

Why revisit this metric view

This metric history becomes more useful after the next quarterly or annual filing because the latest reported value, period, and company comparison context can all change.

Latest source-backed update
Latest period end 31 Dec 2020
Why come back
Return after the next filing to verify whether this metric changed and how it compares with the ranking page.
  • Current latest reported period: Q4 2020.
  • Latest reported value on this page: CA$6,883,461.
  • Save this filer if you want to compare the next reported value with this history.

Metric freshness comes from the latest SEC company fact available for this taxonomy tag and the paired company facts page.

Latest update

Latest update for Noncurrent Liabilities

New fact period available

Latest reported noncurrent liabilities: CA$6,883,461. Open the source-backed page to compare this metric with the newest filing-backed context.

Update date

31 Dec 2020

Page type

Metric history

Latest period

Q4 2020

SEC-backed company facts were refreshed from filings filed on 13 Nov 2026.

Benchmark Context

How Noncurrent Liabilities compares with peers

ONCOLYTICS BIOTECH INC sits in the upper half of the current noncurrent liabilities sample.

Compared with

Compared with 4 companies reporting noncurrent liabilities in CAD. This keeps the comparison on the same metric and unit family.

Why this is notable

This is about 1x the current sample midpoint. Noncurrent Liabilities is roughly flat versus the comparable prior period.

  • Visible rows currently span reported period ends from 31 Jul 2020 to 31 May 2025.
  • Nearby companies in this sample: Versus Systems Inc. and ADURO CLEAN TECHNOLOGIES INC..
  • Current sample position: rank #2 of 4 comparable companies.
  • Peer rows use the latest valid value per company for this exact metric and compatible units.

Peer comparisons use the same metric and compatible units only. Latest reported periods may differ across companies, so open each company page before drawing conclusions.

Financial Metric Page

ONCOLYTICS BIOTECH INC: Noncurrent Liabilities

Latest period: Q4 2020. Period end: 31 Dec 2020. Units: CAD. Frequency: quarterly.

Noncurrent Liabilities is reported in company XBRL facts filed with the SEC.

What this metric tells you

  • Shows reported noncurrent liabilities over 31 Dec 2016 - 31 Dec 2020.
  • Includes year-over-year change points to highlight acceleration or slowdown.
  • Built from 5 SEC fact rows for this metric and issuer.

How to read this chart

  • Start with the latest point, then compare it with the prior periods to see direction.
  • Use quarterly sequence to compare like-for-like periods.
  • Use YoY change bars to separate growth from contraction across matching periods.

Compare This Metric Across Companies

Compare latest available Noncurrent Liabilities levels across SEC-reporting companies, then open each company metric page for SEC-backed verification. Reporting periods may differ by company.

ONCOLYTICS BIOTECH INC appears at rank #2 in the latest comparison sample.

Rank Company Latest value Report period Next step
1 Versus Systems Inc. (vs) CA$8,610,395 Instant - 31 Dec 2020 Open Versus Systems Inc. Noncurrent Liabilities
2 ONCOLYTICS BIOTECH INC (oncy) CA$6,883,461 Instant - 31 Dec 2020 Open ONCOLYTICS BIOTECH INC Noncurrent Liabilities
3 ADURO CLEAN TECHNOLOGIES INC. (adur) CA$513,385 Instant - 31 May 2025 Open ADURO CLEAN TECHNOLOGIES INC. Noncurrent Liabilities
4 BriaCell Therapeutics Corp. (bctx) CA$191,572 Instant - 31 Jul 2020 Open BriaCell Therapeutics Corp. Noncurrent Liabilities

Metric Details

Metric identity Names, identifiers, and filing context for this profile. 1 identity field
Taxonomy
ifrs-full
Metric coverage 3 source fields
Units tracked
CAD
History range
31 Dec 2016 - 31 Dec 2020
Freshness: From parsed SEC XBRL facts on this page
Facts on this page
5
Source: SEC company facts API
Source evidence Original filing metadata and source links for verification. 1 source field
SEC metric endpoint
Open SEC company concept

Chart Context

Compare periods with the same frequency first, then use YoY and TTM series to confirm whether changes are structural or one-off.

Noncurrent Liabilities, Quarterly (CAD)
Noncurrent Liabilities, YoY Quarterly Change (%)

ONCOLYTICS BIOTECH INC Quarterly Noncurrent Liabilities (CAD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2020 CA$6,883,461 -CA$13,255 -0.19% 31 Dec 2020 20-F 05 Mar 2021 2020 FY
Q4 2019 CA$6,896,716 +CA$1,041,401 +18% 31 Dec 2019 20-F 05 Mar 2021 2020 FY
Q4 2018 CA$5,855,315 +CA$1,218,380 +26% 31 Dec 2018 20-F 06 Mar 2020 2019 FY
Q4 2017 CA$4,636,935 +CA$4,636,935 31 Dec 2017 20-F 15 Mar 2019 2018 FY
Q4 2016 CA$0 31 Dec 2016 20-F 19 Mar 2018 2017 FY
* marks a reported value that did not pass the local value check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .